Corrigendum

Corrigendum to “Influence of a 10-Day Mimic of Our Ancient Lifestyle on Anthropometrics and Parameters of Metabolism and Inflammation: The “Study of Origin””

Table 1

Anthropometrics and clinical chemical indices at baseline and at the study end.

UnitBaselineStudy endChange value
MedianRangeMedianRangeMedianRangeSD95% CI of the mean

Body weightkg5568.048.4–116.365.0046.9–111.8−3.4−7.5 to −0.72.0−4.4 to −3.3<0.001
AgeYears503822–67NMNMNMNMNMNMNM
Heightcm55175154–203NMNMNMNMNMNMNM
BMIkg/m25522.4017.4–31.921.316.8–30.4−1.2−4.4 to −0.20.6−1.4 to −1.1<0.001
Hip circumferencecm4410085–1209686–115−3−17 to 53.3−4.2 to −2.2<0.001
Waist circumferencecm448166–1107663–101−5−18 to 95.5−7 to −4<0.001
Waist/hip ratiocm/cm440.840.72–1.000.800.66–0.94−0.02−0.14 to 0.100.06−0.04 to −0.02<0.002

Glucosemmol/L534.94.2–5.84.33.3–6.1−0.6−1.7 to 0.50.6−0.8 to −0.5<0.001
HbA1c%535.34.8–6.15.34.7–6.1−0.1−0.4 to 0.20.2−0.1 to −0.05<0.001
InsulinmU/L2314.03.7–36.86.71.1–12.9−4.7−31.4 to −0.28.1−12.2 to −5.2<0.001
HOMA-IRmmolmU/L2223.00.8–7.91.40.2–2.6−1.2−7.0 to −0.41.8−2.8 to −1.3<0.001

Triglyceridesmmol/L530.690.34–6.680.520.37–2.77−0.14−6.12 to 2.180.92−0.52 to −0.01<0.001
Total cholesterolmmol/L535.23.2–8.24.52.6–8.1−0.7−2.8 to 0.40.7−1.0 to −0.6<0.001
HDL-cholesterolmmol/L532.00.7–3.11.91.0–3.50.0−0.8 to 0.60.3−0.1 to 0.10.464
LDL-cholesterolmmol/L523.01.3–5.82.50.0–5.4−0.6−3.1 to 0.60.7−0.8 to −0.5<0.001
TG/HDL-cholesterol ratiomol/mol530.30.16–9.540.260.11–1.73−0.55−8.98 to 1.341.3−0.59 to 0.98<0.001

ASATIU/L532214–523311–7511−8 to 5411.49 to 15<0.001
ALATIU/L532011–422512–476.0−13 to 527.35 to 9<0.001
CRPmg/L420.610.14–27.041.360.14–41.650.56−15.72 to 41.078.450.20 to 5.46<0.001

TSHmU/L421.250.02–3.121.110.02–4.40−0.08−0.93 to 1.280.47−0.19 to −0.100.326
FT4pmol/L4210.87.9–19.411.37.8–20.60.1−5.6 to 8.42.3−0.4 to 1.10.378
FT3pmol/L424.42.3–6.53.51.7–8.7−0.8−3.4 to 3.11.0−1.0 to −0.5<0.001

Data are medians (range). ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; BMI, body mass index; CRP, C-reactive protein; FT3, free triiodothyronine; FT4, free thyroxine; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-estimated insulin resistance; LDL, low-density lipoprotein; NM, not measured; TG, triglycerides; TSH, thyroid-stimulating hormone. difference between the values before and after the intervention by Wilcoxon signed rank test at .